US Stock MarketDetailed Quotes

Drugs Made In America Acquisition Corp (DMAA)

Watchlist
  • 10.545
  • +0.005+0.05%
Close Apr 24 16:00 ET
355.55MMarket Cap59.91P/E (TTM)

Drugs Made In America Acquisition Corp (DMAA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-539.19K
-125.18K
-56.11K
-106.66K
-251.24K
Net income from continuing operations
--5.94M
--212.96K
--2.18M
--2.29M
--1.25M
Other non cash items
---6.62M
---279.12K
---2.42M
---2.43M
---1.49M
Change In working capital
--138.85K
---59.01K
--176.6K
--36.16K
---14.89K
-Change in prepaid assets
---6.05K
--21.43K
--21.43K
--21.19K
---70.1K
-Change in payables and accrued expense
--144.9K
---80.44K
--155.17K
--14.97K
--55.2K
Cash from discontinued investing activities
Operating cash flow
---539.19K
---125.18K
---56.11K
---106.66K
---251.24K
Investing cash flow
Cash flow from continuing investing activities
-231.15M
0
0
0
-231.15M
Net other investing changes
---231.15M
--0
--0
--0
---231.15M
Cash from discontinued investing activities
Investing cash flow
---231.15M
--0
--0
--0
---231.15M
Financing cash flow
Cash flow from continuing financing activities
231.69M
130.6K
56K
106.55K
231.4M
Net issuance payments of debt
---900K
--0
--0
--0
---900K
Net common stock issuance
--232.05M
--0
--0
--0
--232.05M
Net other financing activities
--543.97K
--130.6K
--56K
--106.55K
--250.82K
Cash from discontinued financing activities
Financing cash flow
--231.69M
--130.6K
--56K
--106.55K
--231.4M
Net cash flow
Beginning cash position
--1.35K
--717
--822
--923
--1.35K
Current changes in cash
--4.79K
--5.42K
---105
---101
---428
End cash Position
--6.14K
--6.14K
--717
--822
--923
Free cash flow
---539.19K
---125.18K
---56.11K
---106.66K
---251.24K
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -539.19K-125.18K-56.11K-106.66K-251.24K
Net income from continuing operations --5.94M--212.96K--2.18M--2.29M--1.25M
Other non cash items ---6.62M---279.12K---2.42M---2.43M---1.49M
Change In working capital --138.85K---59.01K--176.6K--36.16K---14.89K
-Change in prepaid assets ---6.05K--21.43K--21.43K--21.19K---70.1K
-Change in payables and accrued expense --144.9K---80.44K--155.17K--14.97K--55.2K
Cash from discontinued investing activities
Operating cash flow ---539.19K---125.18K---56.11K---106.66K---251.24K
Investing cash flow
Cash flow from continuing investing activities -231.15M000-231.15M
Net other investing changes ---231.15M--0--0--0---231.15M
Cash from discontinued investing activities
Investing cash flow ---231.15M--0--0--0---231.15M
Financing cash flow
Cash flow from continuing financing activities 231.69M130.6K56K106.55K231.4M
Net issuance payments of debt ---900K--0--0--0---900K
Net common stock issuance --232.05M--0--0--0--232.05M
Net other financing activities --543.97K--130.6K--56K--106.55K--250.82K
Cash from discontinued financing activities
Financing cash flow --231.69M--130.6K--56K--106.55K--231.4M
Net cash flow
Beginning cash position --1.35K--717--822--923--1.35K
Current changes in cash --4.79K--5.42K---105---101---428
End cash Position --6.14K--6.14K--717--822--923
Free cash flow ---539.19K---125.18K---56.11K---106.66K---251.24K
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More